Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

House Maintains Momentum For US OTC Monograph Reform, But Senate Remains A Question Mark

Executive Summary

With a new US Congress just convening, OTC monograph reform advocates face an old problem: the need for Senate action. The House has already cleared an OTC reform measure, as part of a pandemic preparedness bill, in the first days of the legislative session.

Advertisement

Related Content

OTC Monograph Reform Passes House Again As Clock Ticks On Session
Elections Reshape Congress But Not Supplement Industry Regulatory Outlook
Exclusivity Period Allowed By OTC Monograph Reform Likely Up To Conference Committee
House Passes US OTC Monograph Reform And Committee Clears HSA Change
OTC Monograph Legislation Clears Another Hurdle Despite Exclusivity Concerns

Topics

Advertisement
UsernamePublicRestriction

Register

PS124536

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel